Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hyams

Showing results (901-910 of 936) with videos related to

Pageof 94
Sort By:
Inflammatory Bowel Diseases|January 16, 2021
Association of Baseline Luminal Narrowing With Ileal Microbial Shifts and Gene Expression Programs and Subsequent Transmural Healing in Pediatric Crohn DiseaseAllison D Ta, Nicholas J Ollberding, Rebekah Karns, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 23, 2010
Factors that determine risk for surgery in pediatric patients with Crohn's diseaseMarc E Schaefer, Jason T Machan, David Kawatu, et al.
Inflammatory Bowel Diseases|February 21, 2018
Free and Bioavailable 25-Hydroxyvitamin D Concentrations are Associated With Disease Activity in Pediatric Patients With Newly Diagnosed Treatment Naïve Ulcerative ColitisCary G Sauer, Matthew S Loop, Suresh Venkateswaran, et al.
JACC. Cardiooncology|November 29, 2022
Cellular and Molecular Mechanisms of MEK1 Inhibitor-Induced CardiotoxicityTyler C Beck, Dimitrios C Arhontoulis, Jordan E Morningstar, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 28, 2018
Biologics Delay Progression of Crohn's Disease, but Not Early Surgery, in ChildrenBasavaraj Kerur, Jason T Machan, Jason M Shapiro, et al.
Science (New York, N.Y.)|January 26, 1996
Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agentJ Linnen, J Wages, Z Y Zhang-Keck, et al.
Gastroenterology|October 29, 2013
Increased effectiveness of early therapy with anti-tumor necrosis factor-α vs an immunomodulator in children with Crohn's diseaseThomas D Walters, Mi-Ok Kim, Lee A Denson, et al.
Cell Host & Microbe|March 18, 2014
The treatment-naive microbiome in new-onset Crohn's diseaseDirk Gevers, Subra Kugathasan, Lee A Denson, et al.
Journal of Pediatric Gastroenterology and Nutrition|May 27, 2022
Utilization of Antitumor Necrosis Factor Biologics in Very Early Onset Inflammatory Bowel Disease: A Multicenter Retrospective Cohort Study From North AmericaBasavaraj Kerur, Karoline Fiedler, Marisa Stahl, et al.
Inflammatory Bowel Diseases|March 22, 2018
Enhanced Contribution of HLA in Pediatric Onset Ulcerative ColitisSuresh Venkateswaran, Jarod Prince, David J Cutler, et al.
Pageof 94

Showing results (901-910 of 936) with videos related to

Sort By:
Pageof 94
Inflammatory Bowel Diseases|January 16, 2021
Association of Baseline Luminal Narrowing With Ileal Microbial Shifts and Gene Expression Programs and Subsequent Transmural Healing in Pediatric Crohn DiseaseAllison D Ta, Nicholas J Ollberding, Rebekah Karns, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 23, 2010
Factors that determine risk for surgery in pediatric patients with Crohn's diseaseMarc E Schaefer, Jason T Machan, David Kawatu, et al.
Inflammatory Bowel Diseases|February 21, 2018
Free and Bioavailable 25-Hydroxyvitamin D Concentrations are Associated With Disease Activity in Pediatric Patients With Newly Diagnosed Treatment Naïve Ulcerative ColitisCary G Sauer, Matthew S Loop, Suresh Venkateswaran, et al.
JACC. Cardiooncology|November 29, 2022
Cellular and Molecular Mechanisms of MEK1 Inhibitor-Induced CardiotoxicityTyler C Beck, Dimitrios C Arhontoulis, Jordan E Morningstar, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 28, 2018
Biologics Delay Progression of Crohn's Disease, but Not Early Surgery, in ChildrenBasavaraj Kerur, Jason T Machan, Jason M Shapiro, et al.
Science (New York, N.Y.)|January 26, 1996
Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agentJ Linnen, J Wages, Z Y Zhang-Keck, et al.
Gastroenterology|October 29, 2013
Increased effectiveness of early therapy with anti-tumor necrosis factor-α vs an immunomodulator in children with Crohn's diseaseThomas D Walters, Mi-Ok Kim, Lee A Denson, et al.
Cell Host & Microbe|March 18, 2014
The treatment-naive microbiome in new-onset Crohn's diseaseDirk Gevers, Subra Kugathasan, Lee A Denson, et al.
Journal of Pediatric Gastroenterology and Nutrition|May 27, 2022
Utilization of Antitumor Necrosis Factor Biologics in Very Early Onset Inflammatory Bowel Disease: A Multicenter Retrospective Cohort Study From North AmericaBasavaraj Kerur, Karoline Fiedler, Marisa Stahl, et al.
Inflammatory Bowel Diseases|March 22, 2018
Enhanced Contribution of HLA in Pediatric Onset Ulcerative ColitisSuresh Venkateswaran, Jarod Prince, David J Cutler, et al.
Pageof 94